JHS Svendgaard Laboratories Limited has informed the Exchange regarding appoved the JHS Svendgaard Laboratories Employee Stock Options Scheme in its Board Meeting held on August 21, 2025.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of JHS Svendgaard Laboratories approved the 'JHS Svendgaard Laboratories Employee Stock Option Scheme – 2025' on August 21, 2025. The scheme creates a pool of 40 lakh stock options, each convertible into one equity share of Rs. 10 face value, to be allotted directly by the company to eligible employees. As of the announcement date, no options have been granted yet. The exercise price will be linked to the market price at the time of grant, with possible discounts allowed but not below face value. Vesting will happen over 1 to 5 years from the grant date, and vested options must be exercised within 5 years.
This introduces potential dilution of up to 40 lakh new equity shares for existing shareholders, though no grants have been made yet. ESOP schemes are generally aimed at employee retention and aligning management interests with shareholders, but investors should monitor future grants and dilution impact.